PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | PRICE T ROWE ASSOCIATES INC | 1,480,194 2.700% | -1,398,520 (-48.58%) | Filing |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | PRICE T ROWE ASSOCIATES INC | 2,878,714 5.300% | 2,878,714 (New Position) | Filing |